Hematopoietic and Lymphoid Cell Neoplasm

Oncology·MeSH: Hematologic Neoplasms

12 drugs in development·4 companies·25 clinical trials

Drug Pipeline by Phase

Phase 3(5)

Drug	Company
fludarabine phosphate	Filana Therapeutics Inc. (FLNA)
infliximab	GH Research PLC (GHRS)
intravenous immunoglobulin therapy	GH Research PLC (GHRS)
Tacrolimus	Filana Therapeutics Inc. (FLNA)
Thiotepa	Filana Therapeutics Inc. (FLNA)

Phase 2(7)

Drug	Company
Busulfan	Filana Therapeutics Inc. (FLNA)
itacitinib	JOHNSON & JOHNSON (JNJ)
Mycophenolate mofetil	Filana Therapeutics Inc. (FLNA)
Mycophenolate Mofetil	Merus N.V. (MRUS)
Tacrolimus	Merus N.V. (MRUS)
Thiotepa	Merus N.V. (MRUS)
TIL	Filana Therapeutics Inc. (FLNA)

BioSniper tracks 12 drugs in development for Hematopoietic and Lymphoid Cell Neoplasm across 4 companies.

There are 25 clinical trials targeting Hematopoietic and Lymphoid Cell Neoplasm tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.